Oncology & Cancer
Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine
A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted ...
Jul 24, 2014
0
0